Code Compliance Promotion Committee
We support our member companies to comply with relevant laws and regulations, guidelines and voluntary codes, and to fulfill their social responsibilities with high ethical standards as members of life-related industries. It also promotes activities as the committee in charge of the "Guidelines for Marketing Information Provision Activities of Ethical Drugs".
Announcements and Updates
-
Code Compliance Promotion Committee
Updated "FAQs related to changes in the industry standard manual "EDI Uniform Data Format" and JD-NET's 8th system renewal.
-
Code Compliance Promotion Committee
Report on "FY2025 Meeting of Code Administration Managers and Practitioners" is now available.
-
Code Compliance Promotion Committee
Publication of the book "Pharmaceutical Association Code of Practice (Revised May 2025)
-
Code Compliance Promotion Committee
The article by Mr. Kondo, Chairman of the Product Information Outline Review Committee, was published in the "Nikkan Yakugyo".
-
Code Compliance Promotion Committee
The "Transparency Guideline for the Relationship between Corporate Activities and Medical Institutions" for the payment in FY2024 has been updated.
Contents of Code Compliance Promotion Committee
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Charter of Corporate Behavior of the Pharmaceutical Manufacturers Association of Japan
In 1997, the Pharmaceutical Manufacturers Association of Japan (PMAJ) established the "PMAJ Charter of Corporate Behavior" to help member companies fulfill their missions as pharmaceutical companies.
-
Pharmaceutical Association Code of Practice
The "Pharmaceutical Manufacturers Association of Japan Code of Practice," which covers interactions between all executives and employees of member companies and researchers, medical professionals, patient groups, etc. is posted.
-
Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions
Transparency Guidelines for Relationships between Corporate Activities and Medical Organizations, etc. are explained.
-
Product Information Summary Review Meeting
Priority issues of the Product Information Summary Review Committee are listed.
-
Communication on GL for Sales Information Provision Activities
Information on "Guidelines for Marketing Information Provision Activities for Ethical Drugs" as an oversight committee is posted.
-
Announcement from the Code Compliance Promotion Committee
Various announcements from the Code Compliance Promotion Committee are posted.